dndn $26.20 in after hours trade, page-8

Just posted on CNBC website
E-Trade shares tumble; Dendreon shares leap,

DNDN 11.84, -9.71, -45.0%) shares more than doubled to $26.30 following a trading halt. Earlier Tuesday, results from a Phase 3 trial of its Provenge vaccine showed that the treatment extended the lives of patients with advanced prostate cancer by 4.1 months compared with a placebo, bringing the median survival rate to 25.8 months.
But Dendreon's shares during the regular session suddenly reversed from their higher course and dropped 45%, prompting a trading halt. Nasdaq OMX Group officials reviewed the potentially erroneous trades and later decided to let them stand.

http://www.marketwatch.com/news/story/E-Trade-shares-sink-after/story.aspx?guid={3B8FD34E-5C26-4C28-844A-E7A6210B64C6}